免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

基因分型测定,丙型肝炎病毒

PMA编号:P120012 · 2021-03-05

决定日期2021-03-05
PMA 编号P120012
产品代码OBF
设备分类第2类
医疗专科M
法规编号21 CFR 8
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。

器械摘要

Assay, genotyping, hepatitis c virus is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Molecular. It received FDA 510(k) clearance on 2021-03-05. The device is classified under product code OBF. It was reviewed by the MI advisory panel.

常见问题

What is the Assay, genotyping, hepatitis c virus?

Assay, genotyping, hepatitis c virus is a medical device that received FDA 510(k) clearance on 2021-03-05. The listed applicant is Abbott Molecular.

When did Assay, genotyping, hepatitis c virus receive FDA 510(k) clearance?

The clearance date for Assay, genotyping, hepatitis c virus can be found in the official FDA records.

Who is the listed applicant for Assay, genotyping, hepatitis c virus?

The FDA 510(k) record lists Abbott Molecular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Assay, genotyping, hepatitis c virus?

The FDA product code for Assay, genotyping, hepatitis c virus is OBF.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑